DFTX
NASDAQ · Pharmaceuticals
Definium Therapeutics Inc
$35.12
+1.85 (+5.56%)
Open$33.52
Previous Close$33.27
Day High$35.34
Day Low$33.35
52W High$49.70
52W Low$10.47
Volume—
Avg Volume1.70M
Market Cap4.43B
P/E Ratio—
EPS$-3.43
SectorPharmaceuticals
Analyst Ratings
Strong Buy
24 analysts
Price Target
+31.0% upside
Current
$35.12
$35.12
Target
$46.00
$46.00
$39.37
$46.00 avg
$57.04
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 685.27M | 628.04M | 535.94M |
| Net Income | 136.42M | 119.21M | 84.03M |
| Profit Margin | 19.9% | 19.0% | 15.7% |
| EBITDA | 222.00M | 198.31M | 161.40M |
| Free Cash Flow | 100.39M | 95.21M | 82.42M |
| Rev Growth | -7.8% | +7.1% | -9.9% |
| Debt/Equity | 0.71 | 0.57 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,411.95 | +4.28% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $282.11 | +2.13% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $148.76 | +1.38% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.23 | -0.54% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | +0.00% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $82.32 | +3.68% | 12.8 | 33.59B |